I thought the report was slightly negative, so I didn't buy more. No new news about the transition except being a little below guidance. Did I miss something positive?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025